Tailin Biotech announced that the company's wholly-owned subsidiaries Tailin Life Sciences, Tailin Medical Engineering, and Tailin Analytical Instruments recently obtained a total of 13 patent certificates, including 1 invention patent. The most authorization announcement date is July 14, 2026; only the patent authorization date for “a vaginal discharge dyeing solution and its preparation method and dyeing method” is July 7, 2026. The acquisition of the above patents has had no significant impact on recent production and operation, but it is conducive to improving the intellectual property protection system and enhancing core competitiveness.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.